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Abstract: 
 
Background: Techniques are emerging for determining the best and most cost-effective 
way to test for human milk adulteration. Currently, the literature is focused on the use of 
qPCR testing, a technique used to isolate and amplify pieces of DNA for analysis. 
However, no recommendation currently exists on the best DNA extraction kit to use to 
achieve optimal DNA yield or purity from human milk samples for downstream qPCR use. 
Thus, the objective of this study is to assess and compare two DNA extraction kits for use 
with human milk samples for future DNA-based analysis in the testing for bovine milk 
adulteration in human milk. 
Methods: Forty mothers pumped human milk samples under the observation of a 
researcher using a brand-new hand pump. Eight unadulterated samples were then randomly 
chosen for DNA-extraction. The eight samples were thawed, pooled, and DNA was 
isolated using the Omega Bio-Tek's E.Z.N.A.® Blood DNA Mini Spin Kit and the Norgen 
Biotek Corporation Plasma/Serum Circulating DNA Purification Mini Kit (Slurry Format) 
per the protocols included in the kits on arrival. An overnight incubation modification was 
also added to both kits to try to obtain optimal yield and purity. UV/VIS spectroscopy was 
used to determine DNA yield and purity using the ThermoFisher Scientific NanoDrop 
2000TM 260/280 ratio, and a cost comparison was done between kits.  
Results: The Norgen kit with no modification provided 143% more DNA than the E.Z.N.A 
kit with no modifications. Similarly, the average nucleic acid yield was 134% greater when 
comparing the Norgen and E.Z.N.A kit with an overnight incubation. The Norgen kit 
provided a 17.0% greater 260/280 ratio and an 11.4% greater 260/280 ratio than the  
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E.Z.N.A. kit, with and without modifications, respectively. The Norgen kit costs $2.37 
more per extraction than the E.Z.N.A kit. Modifying both DNA extraction kits with an 
overnight incubation decreased the average nucleic acid yield and purity of the resulting 
DNA. 
Conclusion: From these results, the Norgen kit without overnight incubation is a better 
extraction kit for DNA extraction from raw human milk for both nucleic acid yield and 
purity. However, the EZNA kit costs less per extraction at $1.45 vs. $3.82. For extraction 
purposes, purity should be prioritized over nucleic acid yield because contaminants can 
compromise results and shorten the shelf-life of samples. 
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Introduction 
 The term breastfeeding can encompass many definitions. It not only includes the 
feeding of infants via the breast of ones' mother, but it also includes the cross- or shared 
feeding and the use of human milk in general1. Human milk provides a variety of benefits 
to both preterm and term infants containing many protective antibodies and nutrients that 
aid in the infant’s physiological and psychological development. According to the World 
Health Organization (WHO) and the American Academy of Pediatrics (AAP), 
breastfeeding is one of the most effective ways to ensure child health and survival, and it 
is recommended that mothers exclusively breastfeed their infant for at least the first six 
months for optimal development2,3.  
 The definition of exclusive breastfeeding is the consumption of human milk with 
no other solids, water, or liquids, unless medically indicated,2 and while many infants do 
receive human milk in some capacity, The Center for Disease Control’s Breastfeeding 
Report Card reports that in 2015 the percentage of infants breastfed at all through six 
months was 57.6%, and 24.9% of infants were breastfed exclusively for the recommended 
duration of at least 6 months nationally4. In South Carolina alone in 2015, only 45.1% of 
infants were breastfed at all in the first 6 months of life, and 24.4% of infants were breastfed 
exclusively, which is below the national average for both categories4. There are many 
reasons as to why infants are not exclusively breastfed for the recommended duration of at 
least six months, some of which include delayed milk production, inadequate supply, 
difficulty with transfer, and maternal or infant medical conditions5. If mother’s own milk 
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(MOM) is unavailable, other options are necessary to meet both the infant’s nutritional 
needs and the mother’s breastfeeding goals.  
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Chapter 1: The History of Breastfeeding 
 Women have been breastfeeding for a very long time, with records dating back to 
2000 BC in Israel6. Breastfeeding was the only way mothers were able to feed their infants, 
and without it, they were at a greater risk for illness or death due to the lack of other safe 
feeding methods available at that time 6,7. Throughout history, breastfeeding has been 
considered the preferred method of infant feeding among healthcare professionals because 
of the ease in absorption and digestibility and due to the changing nutrient composition 
based on an infant's developmental needs6. However, when mothers were unable to 
breastfeed due to lactation failure, illness, separation, or death, shared lactation or wet 
nursing was the common alternative; or the sharing of expressed milk to another parents’ 
infant1.  
Shared Lactation & Wet Nursing 
 For many early cultures, specifically hunter-gatherer cultures, shared lactation was 
a common practice, ensuring nourishment for all children within a family1. As cultures 
became more socially structured throughout both Europe and America in the 1700s, wet 
nursing was a safe feeding alternative, and became a social status for women of a higher 
social strata1. Breastfeeding at this time was considered socially unacceptable for those of 
higher class, and so the job proceeded to be carried out by mothers in poorer 
communities1,6. This allowed wealthier women to focus their time on aristocratic and social 
efforts instead of breastfeeding6,7. During the early 1800s, rural-slave owners often 
assigned slaves to nurse their infant. Allowing slaves to breastfeed their infants had its 
benefits to slaveowners, because it meant continued maximization of labor6. Many times, 
   4 
 
the slaveowners infants were breastfed to the detriment of the slave’s own children. It 
wasn’t until the 19th century when artificial feeding was developed that overall 
breastfeeding and wet nursing rates began to decline.  
Alternative Feeding Methods 
Animal Milks 
 In the 19th century, agricultural societies began to develop. The close proximity of 
farm animals like cows, goats, and donkeys made it possible for infants to be taken directly 
to the animals’ teat for feeding1. Goats and donkeys were most often used because it was 
thought that their milk was most similar to that of human milk1. However, as cultures 
continued to evolve and families moved further and further away from the country and into 
the developing cities, the use of dairy milk in a bottle emerged1. Bottle feeding allowed 
women to work away from home while also providing adequate nutrition for their 
children1. However, the consumption of unpasteurized, contaminated dairy caused an 
increase in infant morbidity and mortality due to inadequate milk storage and sterilization1. 
Many infants and children became ill as a result of the contamination, with 18% of infants 
dying before their first birthday due to gastrointestinal infections or diarrhea1. Before the 
development of refrigerated cars, cow's milk was often shipped via railway cars resulting 
in high amounts of bacteria during hot summer months6. It was also common for dairymen 
to dilute the cow and donkey milk they were supplying with water, and when the milk 
began to look gray they would adulterate it with chalk to make it look more white and 
creamy. It wasn’t until several campaigns and decades later that testing began on how to 
best seal, bottle, pasteurize and ship dairy products safely1.  
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Infant Foods & Formula 
  Eventually, an infant food was developed by a man by the name of Justus von 
Liebig in 1865. He was a chemist and his "formula" consisted of cow's milk, wheat and 
malt flour, and potassium bicarbonate. Food preservation continued to advance with the 
development of sealed containers and eventually evaporated milk was patented. Many 
different evaporated formularies were created, and after the first initial development of 
Liebig's formula with cow's milk, other commercial companies began to experiment in the 
creation of other infant foods that came in a variety of forms from liquids to powders. 
 Unfortunately, infant formulas cannot change in composition as breast milk does, 
based on the needs of the infant, nor did they have the same nutrient density when they 
were first created6. Additionally, these new formulas consisted of added carbohydrates, 
were high in fat, and contained few vitamins or minerals. Micronutrients were eventually 
added; however, as with previous efforts, the development of these infant foods and 
formulas resulted in increased infant mortality due to inadequate milk storage resulting in 
gastrointestinal upset8. To solve these issues, industry developed easy-to-clean bottles and 
the in-home iceboxes. It wasn't until the 1920s that nonmilk-based formulas were 
developed due to infant allergy and intolerance to cow's milk. Again, these formulas lacked 
essential nutrients and had to be fortified. During this period, what physicians suggested 
was held in high regard by the public, and so formula companies began targeting their 
marketing campaigns towards physicians. Sales representatives of these formula 
companies would often pretend to be medical professionals and integrate themselves into 
the healthcare social society giving gifts in exchange for hearing their sale’s pitch. The 
relationship between physicians and formula companies resulted in the removal of the 
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instructions on formula cans replacing them with a message to consult their physician on 
what is best. As a result of popular demand for formula and the support from physicians in 
its safety, breastfeeding rates declined6.  
 In the late 1970s, many infants were becoming ill because women were diluting 
their infant formulas to make them last longer due to inadequate income. Infants in 
underdeveloped countries were also becoming ill due to using contaminated water in their 
formula preparation. As a result, physician attitude regarding formula began to change, and 
breastfeeding rates began to rise8. This caused formula manufacturers to target consumers 
to ensure the success of their products. In 1974 the World Health Organization (WHO) put 
out a resolution stating that breastfeeding was the most appropriate nutritional solution for 
infants. The resolution also noted that the decline in breastfeeding was related to 
misleading advertisements by formula companies on the quality of their products, 
ultimately contributing to infant mortality in the developing world1. In 1990 the American 
Academy of Pediatrics put out a statement opposing formula advertisements, bringing to 
light to the impact they were having on breastfeeding rates and infant nutrition6. According 
to the CDC’s most recent breastfeeding report card (2015) 83.2% of infants started out 
breastfeeding at birth, providing evidence that most mothers want to breastfeed their 
infants4.  
Donor Human Milk Banks 
 In the early 1900s, physicians began to recognize that feeding human milk 
increased survival rates of premature infants of earlier gestational ages and infants with 
more complex illnesses, and as a result of technological and medical advances, donor milk 
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banks were established. Donor milk banks provide milk to premature or critically ill infants 
whose mothers may not have an adequate supply yet due to pre-term birth and dyad 
separation. The first milk bank was established in Vienna in 1909, and then two more in 
1910; one in the United States and the other in Germany1. Through education and support 
for other institutions, milk banking continued to increase in both Canada and the United 
States. By the 1940s, the AAP had developed guidelines for donor milk banking and by 
the early 1980s, there were 30 milk banks in the United States providing for primarily 
premature or critically ill infants1. The Human Milk Banking Association of North America 
(HMBANA), anon-profit organization that was founded in 1985, was established to 
standardize donor milk baking operations1. Mothers in the U.S. and Canada can donate 
their milk to HMBANA milk banks to support the provision of human milk to fragile and 
premature infants. 
  In the mid-1980s, the potential transmission of two viruses through human milk 
raised concerns. Cytomegalovirus (CMV) and Human Immunodeficiency Virus (HIV), 
both of which have detrimental effects on infants1. Many milk banks closed as a result of 
decreased milk orders due to fear of transmission. To address the concerns, requirements 
for both screening and heat processing of all donor milk were suggested. Unfortunately, 
several milk banks closed due to a lack of funding for these additional processing steps. 
The development of specialty formulas for preterm infants at this time also caused a 
detrimental drop in the number of milk banks in North America, reaching an all-time low 
in 19901. 
 However, when younger-gestational-age infants continued to survive as a result of 
continued medical advances and because of research on appropriate nutrition for preterm 
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infants, there was a revival in both awareness of human milk and the impact that donor 
human milk can have on preterm infant morbidity and mortality1. Today, 29 nonprofit milk 
banks exist in North America with more than 500 banks operating worldwide1,9. In 2019, 
7.4 million ounces of pasteurized donor human milk was donated to fragile babies in both 
Canada and the United States, representing a one-million-ounce increase over 2018. Of 
this 7.4 million ounces, over five million ounces were being received in hospital NICUs 
and over one million ounces at home10. 
 As milk banking became more popular, for-profit milk banks began to emerge. As 
of 2019, there are two major for-profit human milk banks that exist in the United States 
and provide human milk to NICUs: Prolacta® and Medolac®. Unlike HMBANA, both 
Prolacta and Medolac compensate mothers for their milk in order to obtain the necessary 
volumes to produce their commercial products.  
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Chapter 2: Nutritional Benefits of Human Milk 
 Human milk is similar to that of other living tissues in the body. Just like blood, it 
aids in the transport of nutrients, enhances immunity, affects biological systems, and 
additionally, it influences circadian rhythms and modulates gene expression.1 All of these 
capabilities of human milk aid in the physiological and psychological development of the 
infant. Human milk is extremely specific, as all of its components are based on the needs 
of the infant as they grow, and contains on average 65-90 kcals/dL1. Human milk provides 
macronutrients including lipids, proteins, and carbohydrates, all of which are necessary for 
regular growth and development7. Additionally, infants can receive 100% of their 
micronutrient needs from human milk if the mother is well nourished7.  
 The overall composition of human milk changes throughout the different stages of 
lactation and based on many other factors like gestational age, feeding frequency, and stage 
of the feeding1. Three stages of human milk occur after a baby is born. Colostrum is the 
first stage and is usually only produced for the first three to five days postpartum in small 
volume7. The production of this milk is occurring during Lactogenesis I, which means that 
it is dependent on endocrine or hormonal control that is developed during pregnancy and 
activated after the delivery of the placenta. Colostrum, is high in protein, fat-soluble 
vitamins, and contains many immunological components7. The onset of transitional milk, 
the next stage of human milk production, is called Lactogenesis II. Transitional milk 
usually lasts for about two weeks and is also under autocrine control and the more frequent 
that nipple stimulation and milk removal are occurring, the more milk is produced7. 
Transitional milk is of larger volume than colostrum, and contains higher levels of water-
soluble vitamins. The last stage of human milk is mature milk, and this production occurs 
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during Lactogenesis III. This milk is considered the "maintenance milk" and is highly 
dependent on supply and demand (autocrine control). The more often the breast is emptied 
the more frequently the body is signaled to produce milk7. Throughout a feed, mature milk 
shifts in its composition, with the milk at the beginning of a feed containing more lactose 
and water (foremilk) and the milk at the end of the feeding containing more fat (hindmilk). 
Due to the higher lactose and water levels of more milk, it contains many water-soluble 
vitamins7. Conversely, the high-fat nature of the hind milk means that it contains higher 
levels of fat-soluble vitamins and nutrients7. Complete milk removal is necessary for the 
growth and development of the infant to ensure that they are receiving a balanced intake 
of water- and fat-soluble nutrients.  
Macronutrients in Human Milk 
Lipids 
 Lipids provide the greatest source of calories in human milk, making up roughly 
50% of an infant’s daily needs1. The total amount of milk fat does not change, but the 
amount of lipid transferred increases throughout an infant feeding. Human milk contains 
triglycerides, phospholipids, cholesterol, and more than 200 fatty acid structures, including 
linoleic and alpha-linoleic acid11. Triglycerides specifically make up 98% of lipids in milk 
and support the transport of fat-soluble vitamins A, D, E, and K. Long-chain 
polyunsaturated fatty acids (LC-PUFAs) make up 88% of the lipids in human milk1. LC-
PUFAs are the most variable component of human milk, and if the maternal diet is 
supplemented with omega-3 LC-PUFAs, we see that they are preferentially incorporated 
into the milk fat1. The fat in human milk is extremely important for the development of the 
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infant's brain; docosahexaenoic acid (DHA) and arachidonic acid (AA) account for 20% 
of the fatty acid content of the infant's brain. DHA and AA also aid in increasing visual 
acuity, cognitive ability, neurological growth and repair, and nerve myelination1.  
Proteins 
 Another important macronutrient in human milk is protein, with over 400 different 
types available for transfer1. The protein in human milk aids in infant survival by playing 
many roles in the infant’s body, including immune function, endocrine function, structural 
support, and buffering1. Protein also functions to increase the bioavailability of other 
nutrients present in human milk. Casein and whey are the primary proteins present in 
human milk, with their concentrations decreasing as lactation progresses. Casein is 
incomplete and while not easily digestible, it inhibits microbial adhesion. Whey protein, in 
contrast, is easily digestible. They whey-to-casein ratio is about 9:1 when lactation begins 
and levels out to 1:1 in late lactation1. Colostrum contains high levels of whey proteins, 
including alpha-lactalbumin, serum albumin and lactoferrin, as well as enzymes, 
immunoglobulins, and bioactive peptides1.  
Immunoglobulins are a class of proteins that act as antibodies in the immune 
system. There are several different types of immunoglobulins in the human body, however, 
circulating levels of secretory immunoglobulin A (sIgA) are low when infants are born1. 
Human milk allows for the transfer of secretory IgA, which is important because it blocks 
the adhesion of pathogenic microorganisms to the intestinal epithelium and in doing so, 
protects the infant from infection and illness7. The frequent feeding between mother and 
infant is essential to transfer sIgA. 
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Another protein of importance in human milk is lactoferrin. Lactoferrin has many 
roles, with the absorption of iron being one of them, which is necessary for adequate bone 
growth in infants. Lactoferrin attracts iron and binds to it, preventing pathogenic bacteria 
from binding, and thus, reducing the risk for bacterial growth1.  
Lysozyme is another important protein found in human milk. Lysozyme is an anti-
microbial enzyme primarily found in human mucus (gastrointestinal tract and nasal cavity), 
tears, and saliva that functions to prevent the human body from harmful bacteria. The 
presence of lysozyme in human milk protects the infant’s gastrointestinal tract by breaking 
down the cell walls of gram-positive bacteria1.  
 
Carbohydrates 
 The carbohydrate fraction in human milk is made up of complex and simple 
carbohydrates. The primary carbohydrate found in human milk is lactose1 ,7. Lactose 
enhances calcium, magnesium, and manganese absorption and functions as an energy 
source to the infant’s growing brain. Lactose is a disaccharide made up of two 
monosaccharide subunits called glucose and galactose. Glucose is the primary energy 
source for infants and so the breakdown of lactose into glucose is essential for glycolysis. 
Glycolysis yields adenosine triphosphate (ATP) and nicotinamide adenine dinucleotide 
(NADPH), the body’s two high energy molecules12.  
Human milk also contains over 200 specific sugars known as human milk 
oligosaccharides (HMOs). HMOs are the third most abundant component in human milk 
after lactose and fat. These sugars are indigestible by the infant and act as prebiotic 
substrates supporting the colonization of intestinal flora in the gastrointestinal tract11, 
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13,13,14. HMOs also protect the infant from pathogens by acting as a soluble glycan decoy, 
blocking the pathogen’s attachment to epithelial cell surface receptors preventing infection 
and disease development in the gut, urinary and respiratory tracts15,15. By inhibiting 
inflammatory gene expression and reducing the platelet-neutrophil complex which 
develops during inflammation, HMOs have also been shown to have an anti-inflammatory 
effect on an infant’s immune system15,13. 
Table 1: Concentration of Macronutrients in Term Human Milk. 
Macronutrient Average g/mL 
Lipids 0.4-5.2g/dL 
Protein 0.8-0.9g/dL 
Carbohydrates (Lactose) 7.0g/dL 
 
Water 
 Human milk is 87.5% water and provides infants what they need to stay hydrated 
during the first 6 months of life7. As water sources in many developing countries are not 
sterile, maintain breastfeeding and the use of human milk protects against gastrointestinal 
disease from contaminated drinking water. Preparing infant formula requires the use of 
water and so in a developing country, it would be dangerous. In these countries, formula 
preparation is discouraged due to inadequate and contaminated drinking water.  
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     Micronutrients  
Vitamins  
 Human milk is a great source of vitamins and minerals, satisfying most full-term 
infant needs. As lactation advances, the number of water-soluble vitamins in milk increases 
and the level of fat-soluble vitamins decrease as a result of developed infant stores from 
maternal-infant dietary exchanges throughout early lactation1. Vitamin A specifically 
reaches its highest levels within the first week after birth at 200 IU/dL. It presents as mostly 
Retinol and has shown to be essential for infant eye health and development1. Vitamin A 
deficiencies can result in the development of xerophthalmia, and if left untreated, 
blindness1. As Vitamin A deficiency is the leading cause of preventable childhood 
blindness worldwide, breastfeeding is encouraged to protect against deficiencies. 
Colostrum is rich in vitamin E or tocopherol1. Vitamin E is an antioxidant and protects 
against reactive oxygen species (ROS) which at elevated levels causes oxidative stress in 
the body that cause damage to proteins, lipids, and DNA. Preterm and term mothers have 
similar levels of vitamin E (3IU/100kcal) and carotenoid levels1.  
  Vitamin D, which is essential for adequate bone development and growth, and 
vitamin K, which is essential for regular blood coagulation, are both present only in small 
amounts in human require supplementation1,7, 16. Without supplementation, vitamin D 
deficiency in infants can often result in rickets, and a deficiency in vitamin K can lead to 
issues with blood clotting and hemorrhage. The AAP currently recommends 
supplementing 400 IU per day of birth for Vitamin D, and a 1-mg oral dose of vitamin K 
administered at birth, at 1-2 weeks, and 4-6 weeks for breastfed infants1,7. 
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 Water-soluble vitamins like ascorbic acid, nicotinic acid, B12, riboflavin, and B6, 
are influenced by maternal diet, but supplementation is typically not needed if the mother 
is well nourished. Of all of the B-vitamins, folate is especially important for dietary 
consumption as levels in human milk are maintained even if it adversely impacts maternal 
stores of folate. Folate remains at the same levels in human milk throughout lactation, and 
maternal stores diminish slightly from 3-6 months to maintain milk folate levels1.  
Minerals 
 Most minerals are found in consistent amounts in human milk. Mineral levels tend 
to reach their highest concentrations in human milk within the first few days after birth and 
decrease with little variation as lactation advances. The regulation of minerals comes from 
maternal body stores1. Sodium is typically elevated in early colostrum but falls by 3rd day 
postpartum and levels of zinc rise on the 2nd day postpartum and then eventually decline1. 
Zinc is more abundant in colostrum than in mature milk and the bioavailability in human 
milk is due to the low-molecular-weight zinc-binding ligand that acts as a cofactor for zinc 
absorption1. Calcium is observed in small quantities in human milk (20-34mg/dL) but 
absorbed at 67% when compared to that of cow’s milk at 25%. Hypocalcemia can be seen 
in formula-fed infants due to the higher concentration of phosphorus, which leads to 
decreased absorption and increased excretion of calcium1. 
 Small amounts of iron are present in human milk(0.5-1.0mg/L), but newborns are 
rarely iron deficient. Most infants are sustained by iron stores they obtain in utero. 
Additionally, the lactose and vitamin C levels in human milk assist in iron absorption.  
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Copper is also present at high levels in human milk, and also aids in the absorption of iron1. 
Selenium is also higher in human milk than in infant formula, which helps protect against 
oxidative stress. Small amounts of aluminum, iodine, chromium, and fluorine are also 
present in human milk1. 
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Chapter 3: Feeding Options after Early Breastfeeding Cessation 
In 2013, it was found that 60% of mothers do not breastfeed for as long as they 
would like to17. This is influenced by many factors, some of which include: issues with 
latch, low milk supply, concerns about infant nutrition and weight, infant or maternal 
illness, concerns with medication use, and problems with breast pump usage17. The 
duration of breastfeeding has also been shown to be impacted by maternal workplace 
characteristics. Mothers who are supported in the work place and are provided private 
pumping spaces and utilities have higher breastfeeding initiation and duration rates18. 
Despite high rates of early cessation, it is still recommended that mothers exclusively 
breastfeed their infant for at least the first six months and to continue to breastfeed while 
introducing complementary foods until one year of age19. Glucose homeostasis is a 
requirement for the initiation of lactation and so if a mother has Type 1 Diabetes Mellitus, 
she is also at risk for delayed lactation7. Being primipara or having retained placental 
fragments also puts mothers at an increased risk of delayed milk production7. Lactogenesis 
III is also heavily influenced by supply and demand. If an infant isn't feeding due an 
aversion, illness, or tongue-tie the mother may not be adequately emptying her breasts, 
resulting in decreased milk production. All of these reasons are why if MOM is 
unavailable, other options for maintaining an exclusively human milk diet are necessary to 
meet global recommendations, and support the infant’s nutritional needs and the mother’s 
breastfeeding goals.  
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Donor Human Milk 
 Donor human milk (DHM) is breast milk that has been donated for the use in 
hospital and outpatient facilities for mothers of infants, specifically preterm infants, who 
are unable to produce an adequate milk supply. In this way, the infants are still able to 
receive the benefits of human milk for healthy development, regardless of maternal supply. 
There are many reasons as to why mothers donate their excess breast milk. Some women 
do it because it is practical 20. The mother may have an oversupply or need to free up space 
in her freezer20. Others donate for altruistic reasons and enjoy feeling as though they are 
helping other families and babies20. There also can be personal and social benefits resulting 
from the donation of human milk20. A mother may donate due to the recent loss of an infant 
and chooses to donate as part of the grieving process and to decrease postpartum 
discomfort20,21. The use of DHM has also shown to increase breastfeeding rates at 
discharge among neonatal intensive care units (NICU)22,23.  
Both the WHO and AAP reference DHM in their infant-feeding statements as alternatives 
to when a mother’s own milk is not available for use1.  
 Medically, maintaining an exclusively human milk diet has been shown to decrease 
the risk of infants developing certain diseases like necrotizing enterocolitis (NEC). NEC is 
a condition where the intestines of an infant become filled with bacteria resulting in 
inflammation and infection. If left untreated, this can cause destruction of the bowel wall 
and intestinal perforation, which results in stool leakage into the abdomen and death. 
Premature or fragile infants who consume donor human milk have shown to have decreased 
rates of NEC22,24 , and when using in combination with human milk-based fortifiers (HMF) 
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for extremely premature infants, DHM has shown to decrease the incidence of NEC by 
50%, and surgical NEC by 90% when compared to bovine-based human milk fortifiers25.  
  
Non-Profit Milk Banks 
Non-profit milk banks are a way for mothers to donate their excess human milk 
safely and effectively to infants whose mothers cannot provide their own milk. There are 
currently 29 non-profit milk banks located throughout the United States and Canada10.  
Strict standards are in place by The Human Milk Banking Association of North America 
(HMBANA) for the handling and distribution of DHM, to ensure the safety of the DHM 
provided. All donor milk processing can be found on the HMBANA website26.  
 Briefly, for the handling and distribution of DHM to ensure the safety of the DHM 
provided, milk donors must complete a medical and lifestyle history questionnaire and 
undergo several blood tests for conditions such as HIV, syphilis, and hepatitis B; all of 
which can be transferred via breast milk. Once received, the donor milk is transferred into 
a glass flask for pasteurization. Each pool of milk includes the milk from three to five 
donors and is mixed to ensure an even distribution of nutrients. The milk is then pasteurized 
using Holder pasteurization to eliminate any harmful bacteria as well as other infectious 
agents that could be present in the human milk. The milk is pasteurized at 62.5° C for 30 
minutes and then quick-cooled. The pasteurized milk is then frozen and stored at -20° C 
until it is ready to be distributed to outpatient facilities and hospitals26. Following 
pasteurization, the milk is receives repeated biological bacteriological testing to ensure that 
there is not any growth of bacteria after heat processing. The main recipients of DHM from 
HMBANA milk banks are premature or critically ill infants and so these screening and 
   20 
 
heating processes are in place to ensure the safety and protection of these infants from the 
effects of harmful bacteria, disease and contraindicated drugs, medications, and alcohol26. 
For-Profit Milk Banks 
For-profit milk banks provide compensation to the mothers who donate based on 
the volume of milk that they donate. These for-profit companies then pasteurize the human 
milk and sell it to the hospitals. The screening, handling, testing, and preparation of milk 
at for-profit milk banks are considered proprietary. Consequently, the processing methods 
are largely unknown.  
Peer-to-Peer Milk Sharing 
 Peer-to-peer milk sharing is when mothers share milk with other mothers in need 
informally through social media outlets or milk sharing organizations. Two major milk 
sharing organizations in the U.S. are Eats on Feets and Human Milk 4 Human Babies. 
Options for milk sharing also occur among families or friends. While human milk contains 
several benefits over infant formula for preterm infants, some risks may accompany 
unscreened or untested human milk. These include, but are not limited to, the transmission 
of bacteria, viruses, medications, drugs, nicotine, and other contaminants due to maternal 
infection, inadequate handling, and/or inappropriate preparation27. Current health 
authorities including the Food and Drug Administration (FDA) as well as the American 
Academy of Pediatrics (AAP) caution against feeding infants milk from informal sources 
due to these risks. 
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 Despite the recommendation from the FDA and AAP, mothers often share human 
milk informally for altruistic reasons. For example, in one study researchers found that 
83% of recipients who had sought human milk informally had full-term babies and that the 
infant they were requesting milk for was on average 7.1 months old. The primary reason 
the mother was seeking donor milk was due to lactation insufficiency, and 42.2% reported 
that they had lactation insufficiency outside of an infant medical condition5,17. This sheds 
light on the fact that DHM is not just needed for critically ill or preterm infants, but also 
for completely healthy, full-term infants5.  
 While it appears that mothers who receive milk informally are concerned about 
potential contamination and the harm it may cause their infants, the screening methods 
when mothers accept shared milk vary. Many mothers share milk with others who they 
know socially, so the perception of risk for contamination or adulteration may be lower5. 
Some professionals in the field have recently raised concern for the lack of screening and 
analyses occurring among informal milk sharers, specifically related to the risks related to 
adulteration with non-human milk (specifically bovine milk). In one study, eleven of 102 
human milk samples purchased over the internet anonymously contained both human and 
bovine DNA, with ten being at high enough concentrations to rule out accidental 
adulteration28. This can be problematic for infants with underdeveloped GI tracts due to 
prematurity, as bovine milk intolerances or allergies and often can result in gastrointestinal 
distress. Human milk analyses are of importance for the safety of fragile, premature, or 
term infants due to the potential health risks that accompany adulterated milk.  
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Chapter 4: Human Milk Analysis 
 There have been several studies that focus on the analysis of animal milk. Caprine 
or goat, bovine, and buffalo are just a few of the animal milks that have been researched. 
Efforts have focused on determining the best method for detecting adulteration, or the act 
of making something of less pure quality by the addition or removal of another substance 
or material29,30. It is important to identify adulteration in any food item early on to prevent 
potential health risks due to adverse reactions or allergy. In India, due to its higher fat 
content buffalo milk is sold at a higher price30. Even though there are very few nutritional 
differences between buffalo and bovine milk, it has been reported that buffalo milks are 
being adulterated with bovine milk30.  
 There has also been an increased demand for goat milk and goat milk-based 
products in other countries like Greece. Goat milk contains many vitamins and minerals 
and is rich in protein. Additionally, goat milk contains small fat molecules making it easier 
to digest29. Since goats produce a smaller quantity of milk, the price of the milk is higher 
when compared to bovine. Thus, adulteration of goat's milk with bovine milk has been 
observed29. In these situations, the detection of adulteration is key in preventing economic 
loss and potential public health hazards due to animal protein allergies in these countries.  
 PCR is a method primarily used in molecular biology for DNA-based analysis. In 
PCR, sequences of small, specific pieces of DNA that have been isolated from samples are 
amplified through a series of heat cycles. By creating millions of copies, researchers can 
analyze and study specific segments of DNA. To run PCR, DNA extraction of a sample 
must occur first. DNA extraction is a process of purification. First, the membrane of the 
cell is lysed. Then different elements like protein, fat, or RNA can be broken down by 
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enzymes. The solution is then centrifuged to precipitate these elements. The remaining 
solution, containing the DNA further then washed to remove these impurities or 
contaminants. As a result of the washes, you are left with a DNA solution for further 
analysis. UV/VIS spectroscopy is then used to determine the nucleic acid yield and purity. 
Nucleic acids in solution absorb maximally at a wavelength of 260 nm and proteins absorb 
maximally at a wavelength of 280 nm. The absorbance at 260 nm is used to quantify the 
amount of DNA present, and the ratio of absorbance at 260 nm to absorbance at 280 nm is 
used to determine the quality or purity of the sample. A ratio of at or above 1.8 is considered 
“pure” for DNA. 
 Several studies have examined and compared different DNA extraction methods 
using animal milks for the application of PCR. In one study using a food-based DNA 
extraction kit, it was discovered that when raw cow’s milk was mixed with raw buffalo 
milk the presence of cow DNA could be detected at levels as low as 5%30. This study 
reported a range in DNA concentration from 15-18ng/uL and purity (260/280 ratio) of 
1.85-1.88. In another study, using a different food-based DNA extraction kit and overnight 
incubation modification, it was found that when cow's milk was mixed with raw goat's 
milk, the presence of cow DNA could be seen at levels as low as 0.01%29, with thirty-six 
of the forty samples containing the addition of cow’s milk29. This means that 90% of the 
goat and goat milk-based products were adulterated with cow’s milk. While both of these 
studies have shown that the extraction and analysis of DNA from raw animal milk samples 
can aid in the detection of adulteration, there have been few studies that have examined the 
impact of milk processing on DNA extraction or PCR use.  
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 Milk is often pasteurized to destroy harmful bacteria, infectious agents, and to 
increase shelf-life. However, DNA is a heat-sensitive molecule and at high temperatures, 
DNA can denature. More simply, the double-stranded molecule can break and become to 
single-stranded molecules. Thus, it is important to better understand the impact that 
pasteurization can have on the extraction of DNA. In one study, different DNA extraction 
kits were compared for their effectiveness in isolating DNA from raw, pasteurized, 
retorted, and ultra-high temperature (UHT) processed dairy milk31. In retort processing, 
milk is placed in a large vat and heated to a high temperature ranging from 110- 120° C for 
10-30 minutes. In ultra-high temperature processing, milk is placed in small, pressurized 
tubes and heated at higher temperature, from about 135-145° C for 10-15 seconds. This 
study utilized the differential centrifugation combined with Sodium dodecyl sulfate (SDS) 
method for extracting DNA. SDS is a detergent that aids in the solubility of lipids and 
proteins31. What they discovered was that while the mitochondrial DNA yields were 
appropriate for PCR analysis, the range of values was large, and all of the purity ratios 
obtained ranged from 1.10-1.3031. These results show that there could have been other 
molecules (such as free nucleotides, proteins, or other contaminants) present impacting the 
results. This study shows that the heat and pressure the dairy milk endures during 
processing may impact DNA-based analyses, specifically in the yield and purity of 
extraction.  
 While previous studies have demonstrated the effectiveness of using PCR in the 
detection of bovine milk, they have only demonstrated the presence, but have not quantified 
the level of adulteration. Quantitative polymerase chain reaction (qPCR) is a molecular 
method that uses the same principles of PCR, but rather than documenting the amount of 
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amplification after the reaction, qPCR monitors amplification during the reaction. This 
allows for quantification in a more specific, measurable manner.  
 There seems to be variation amongst extraction kits used for downstream PCR and 
qPCR analysis of animal milk. One study compared five DNA extraction approaches in 
regards to their impact on DNA yield and quality when assessing the human breast milk 
microbiome32. The study showed that the extraction method greatly influenced the DNA 
yield and purity (p<0.001)32. Another study compared eleven different DNA extraction kits 
for downstream qPCR use when examining bacterial spores in dairy samples33. For the 
processing of buttermilk and whole milk samples specifically, the milk protein and cream 
fractions were separated before DNA extraction. It was concluded that the use of the 
QIAamp DNA mini kit is appropriate for DNA extraction for a variety of dairy products 
(Buttermilk, Milk, Cream cheese) with minor modifications to the included protocol33. 
Interestingly, when the DNA extracted from the milk cream fraction was analyzed in the 
qPCR machine, no data was recorded33. Previous studies have suggested that the lipid 
content of certain foods like cooking cream, butter, and cheese interfere with the solutions 
and reagents in DNA extraction, and potentially inhibit of qPCR assays34. These results 
suggest that the cream fraction or higher fat content of milk inhibits qPCR amplification.  
 When it comes to human milk analysis, the literature is lacking. Previous studies 
have examined the use of PCR for the detection of bovine milk, but have only been able to 
determine if it is present in the sample, not to what degree. One study published in 2015 
examined the concentration of adulterated human milk samples purchased online using 
qPCR28. What they discovered was that 11 of 102 of the randomly purchased human milk 
samples collected contained both human and bovine DNA, roughly 11%28. Ten of the 
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eleven samples collected also contained higher contamination amounts ruling out 
accidental contamination.  
 While both PCR and qPCR have shown to be promising in the analysis of animal 
milk, there is not a standard protocol in place for human milk DNA-based analysis. Most 
milk-based analyses have only included raw milk, and when processed milk has been 
studied, there appears to be a variation in the DNA yield and purity obtained. There also 
seems to be variation amongst extraction kits used and modifications made to achieve 
optimal DNA yield, purity, and PCR/qPCR amplification.  
Social Implications for Human Milk Adulteration 
 Future human milk-based analyses are necessary to improve the quality and safety 
of human milk exchanges. The literature has demonstrated that informal milk sharing is 
occurring between mothers in an effort to support infant feeding. However, without 
adequate commercial testing methods, infants receiving donated milk may be at risk for 
consuming adulterated milk. The lack of information available on the processing methods 
occurring in for-profit milk banks also raises safety concerns. Fragile and critically ill 
infants are unable to adequately metabolize animal milks and so the consumption of these 
milks often result in detrimental health complications. If affordable human-milk based 
analyses are not developed, social and long-term health implications will continue to rise.  
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Chapter 5: Optimization of DNA Extraction from Human Milk 
Introduction 
 According to the World Health Organization, breastfeeding is one of the most 
effective ways to ensure child health and survival. Human milk provides a variety of 
benefits to both preterm and term infants and contains protective antibodies and nutrients 
that aid in the infant’s physiological and psychological development. Unfortunately, many 
infants are not exclusively breastfed for the recommended duration of at least six months.  
 There are many reasons as to why infants are not exclusively breastfed for the 
recommended duration of six months, some of which include delayed milk production, 
inadequate supply, difficulty with transfer, and maternal or infant medical conditions5. To 
better support these mothers and infants, women with excess breast milk can donate it to 
milk banks. In the United States, there are for-profit and non-profit milk banks. For-profit 
milk banks provide compensation to the mother for her donation based on the volume of 
milk she is providing.  
 Professionals in the field are concerned that with the increased need for human 
milk, there may be an increased rate of adulteration of human milk prior to donation28. This 
can be detrimental to newborns, due to the differing levels of protein and minerals in other 
animal-based milk. This high level of protein and minerals can stress the infant’s kidneys, 
leading to severe illness. Currently, it is reported that one for-profit company screens donor 
milk for bovine adulteration; however, methods for screening are considered proprietary 
and no published protocols exist.   
 Efforts are ongoing to determine the best and most cost-effective way to test for 
human milk adulteration, with previous studies examining the use of qPCR testing, a 
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technique used to isolate and amplify pieces of DNA for analysis. Despite these efforts, the 
most effective approach for isolating DNA from human milk at high concentrations and 
sufficient purities remain unknown. The objective of this study is to assess and compare 
two DNA extraction kits for use with human milk for future DNA-based analysis in the 
testing for bovine milk adulteration in human milk samples.  
Methods 
Sample Preparations 
 All participants provided informed consent and procedures were followed in 
accordance with and approved by the Institutional Review Board at the University of North 
Carolina, Greensboro (UNCG; Greensboro, NC). Forty mothers pumped human milk 
samples under the observation of a researcher using a brand-new hand pump at the UNCG 
campus and then were shipped to Winthrop University (Rock Hill, SC). All human milk 
samples were then de-identified and aliquoted into 2mL microcentrifuge tubes and stored 
at -80° C until analysis. One mL of human milk from 8 unadulterated samples were 
randomly chosen and pooled together in preparation of DNA extraction.  
DNA Extraction 
 DNA was isolated using the Omega Bio-Tek's E.Z.N.A.® Blood DNA Mini Spin 
Kit or the Norgen Biotek Corporation Plasma/Serum Circulating DNA Purification Mini 
Kit (Slurry Format). For both kits 200uL of pooled human milk was utilized to perform 
DNA extraction per the manufacturer’s instructions with no modifications in triplicate. 
Then DNA extraction was completed for each kit with the addition of a 65° C overnight 
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incubation period in triplicate (Figure 1). Isolated DNA was then stored at 4°C in the 
refrigerator. 
DNA Yield and Purity Analysis 
 UV/VIS spectroscopy was used to determine DNA yield and purity using the 
ThermoFisher Scientific NanoDrop 2000™. For each extracted DNA sample, 1 uL was 
pipetted onto the Nanodrop pedestal and nucleic acid concentrations (ng/uL) and 
260/280nm absorption readings for purity were documented.  
 
 
Figure 1. Methods overview. 
Cost Analysis 
 The E.Z.N.A.® Blood DNA Mini Kit and the Norgen Biotek’s Plasma/Serum 
Circulating DNA Purification Mini Kit (Slurry Format) costs per DNA extraction was 
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calculated using total kit cost (Winthrop University purchase price) divided by the number 
of extractions possible per kit.  
Statistical Analysis 
Descriptive statistics and box-and-whisker plots were completed using Microsoft 
Excel 2016 (Redmond, WA).  
Results 
Nucleic Acid Yield 
 Average nucleic acid yields and 260/280 ratios for the four extraction methods are 
reported in Table 1. Descriptive statistics are represented visually in Figure 2. Modifying 
both DNA extraction kits with an overnight incubation decreased the average nucleic acid 
yield with 3.73% decrease and 19.1% decrease in nucleic acid yield for the E.Z.N.A kit 
and the Norgen kit, respectively (Table 2 and Table 3). Based on average nucleic acid yield, 
the Norgen kit with no modifications provided 143% more DNA than the E.Z.N.A kit with 
no modifications (Table 2). Similarly, the average DNA yield was 134% greater when 
comparing average nucleic acid yield when using an overnight incubation (Table 3).  
Purity 
 Descriptive statistics for purity are visualized in Figure 3. Similar to nucleic acid 
yield, adding the overnight incubation decreased the purity of the resulting DNA; with a 
5.92% decrease in the 260/280 ratio and a 10.9% decrease in the 260/280 ratio for the 
E.Z.N.A kit and the Norgen kit, respectively (Table 2 and Table 3). Additionally, the 
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Norgen kit provided a 17.0% greater 260/280 ratio and an 11.4% greater 260/280 ratio than 
the E.Z.N.A kit, with and without modifications, respectively (Table 2 and Table 3).  
Table 2. Descriptive statistics for samples extracted using the E.Z.N.A. Blood DNA Mini 
Kit (EU) and the Norgen Biotek DNA Mini Kit (NU) when using standard kit protocol. 
 
Variable Kit Mean StDev Minimum Median Maximum 
DNA Yield (ng/uL) EU 8.033 1.050 7.000 8.000 9.100 
DNA Yield (ng/uL) NU 48.63 3.38 44.90 49.50 41.50 
260/280 Ratio EU 14633 3.38 14200 1.4700 1.5000 
260/280 Ratio NU 1.7333 0.0252 1.7100 1.7300 1.7600 
 
Figure 2. DNA yield of samples extracted using the E.Z.N.A. Blood DNA Mini Kit (EU) 
and the Norgen Biotek DNA Mini Kit (NU) when using standard kit protocol (P) or 
modified by adding an overnight incubation (I). 
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Table 3. Descriptive statistics for samples extracted using the E.Z.N.A. Blood DNA Mini 
Kit (EU) and the Norgen Biotek DNA Mini Kit (NU) when standard kit protocol was 
modified by adding an overnight incubation. 
 
Variable Kit Mean StDev Minimum Median Maximum 
DNA Yield (ng/uL) EU 7.733 0.451 7.300 7.700 8.200 
DNA Yield (ng/uL) NU 39.37 2.08 37.00 40.20 40.90 
260/280 Ratio EU 1.3767 0.0929 1.3000 1.3500 1.4800 
260/280 Ratio NU 1.5433 0.0153 1.5300 1.5400 1.5600 
 
 
Figure 3. 260:280 ratios of samples extracted using the E.Z.N.A. Blood DNA Mini Kit 
(EU) and the Norgen Biotek DNA Mini Kit (NU) when using standard kit protocol (P) or 
modified by adding an overnight incubation (I). 
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Cost Comparison 
 The Norgen Biotek’s Plasma/Serum Circulating DNA Purification Mini Kit cost 
$2.37 more than the E.Z.N.A. Blood DNA Mini kit, at $3.82 per DNA extraction, a 62% 
increase (The E.Z.N.A.® Blood DNA Mini kit costs $1.45 per DNA extraction).  
Discussion 
 Human milk-based analyses are necessary to improve the quality and safety of 
informal human milk exchanges. Previous studies have examined the use of different DNA 
extraction kits for the analyses of animal milk. Keim et al. (2018) reported that the use of 
the Norgen Biotek Plasma/Serum Circulating DNA Purification Mini Kit provided 
sufficient DNA quantity and purity for downstream qPCR analysis. Our results are in 
agreement with this publication; with the Norgen Kit groups yielding 143% and 134% 
(with and without modification, respectively) greater nucleic acid concentrations and 17% 
and 11.5% (with and without modification, respectively) greater purity when compared 
with the E.Z.N.A. Blood DNA Mini Kit.  
 Previous studies have demonstrated that longer incubation periods can be utilized 
to increase the total concentration of nucleic acid and increased purity, improving the 
opportunity for downstream qPCR use29. The results presented in this paper are not in 
agreement with these studies. The overnight incubation resulted in decreases in total 
nucleic acid yield for the Norgen and E.Z.N.A. kits, respectively. Additionally, the 
overnight incubation resulted in decreased DNA purity for the Norgen and E.Z.N.A. kits, 
respectively.  
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 In order for genomic DNA to be considered pure, the ThermoFisher Scientific 
NanoDrop 2000™ protocol reported that a 260/280 nm absorbance ratio of greater than 1.80 
is needed. Our 260/280 ratios ranged from 1.3 to 1.76 thus demonstrating that neither of 
these extraction kits produced DNA with purity ratios acceptable for downstream qPCR 
use. However, the Norgen kit with and without a longer incubation provided a greater 
increase in purity when compared to the E.Z.N.A kit.  
 This study is the first to investigate the effectiveness of different DNA extraction 
kits for the quantity and quality of DNA extracted from human milk samples.  
 A limitation of this study was that only two DNA extraction kits were evaluated. 
Additionally, this study contained a small sample size, and the research team was only able 
to evaluate the impact of a single modification: overnight incubation. Specific to this 
project, the COVID-19 pandemic reduced the amount of in-person laboratory time 
available for continued analysis. Future research needs to evaluate these kits using larger 
sample sizes, different extraction kits, and additional modifications to achieve optimal 
DNA yield, purity, and PCR/qPCR amplification. 
Conclusion 
 From these results, the Norgen kit without incubation appears to be the most 
effective extraction kit for DNA extraction from raw human milk for both nucleic acid 
quantity and 260/280 purity. However, the EZNA kit is more cost effective per extraction 
at $1.45 (the Norgen kit is $3.82 per sample). For extraction purposes, purity should be 
prioritized over DNA yield because contaminants can compromise results and shorten 
shelf-life of samples. Future studies of DNA extraction kits should include the use of food-
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based kits seen they have been previously used and successful in other raw animal milk-
based extractions. One modification that could be investigated is the removal of both lipid 
and protein layers prior to extraction, as human milk has more overall fat than whole milk 
and this may be impacting the purity of the DNA extraction. Additionally, the use of a 
clean-up kit to re-purify and improve lower than desired 260/280 ratios. Lastly, analysis 
should be done on both pasteurized bovine and human milk in order to see how processing 
further impacts the quality of genomic DNA. 
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